Cell line engineering for imporved fertility treatment
Grant period
2023-07-01 - 2024-01-31
Funding body
European Union
Call number
HORIZON-EIE-2022-SCALEUP-02
Grant number
101114052
Identifier
G:(EU-Grant)101114052
Note: kyron.bio is a female led biotech company on a mission is to unclog bottlenecks in therapeutic protein production, allowing better drugs to reach patients. We are using synthetic biology to engineer mammalian cell lines for improved bioproduction, harnessing highly efficient enzymes from diverse life forms. Our preliminary data demonstrates a 3X yield gain for the amount of therapeutic produced in our system, with further gains in yield, activity and stability predicted post optimisation
Recent Publications
There are no publications
Record created 2023-08-27, last modified 2023-08-27